General Information of This Metabolic Reaction (MR) (ID: MR002086)
Formula
SVG example
Oxidtive Deamination
Reactant Ponatinib hydrochloride Product Ponatinib metabolite M3
Reactant Info Product Info
Metabolic Type Oxidation - Oxidtive Deamination
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR002083 Ponatinib hydrochloride AP24567 Oxidation - N-Demethylation Ponatinib hydrochloride [1], [2], [3]
MR002084 Ponatinib hydrochloride AP24592 Hydrolysis - Amide Hydrolysis Ponatinib hydrochloride [2]
MR002085 Ponatinib hydrochloride AP24600 Hydrolysis - Amide Hydrolysis Ponatinib hydrochloride [2]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR002082 Ponatinib metabolite M3 Ponatinib metabolite M4 Oxidation - Oxygenation Ponatinib hydrochloride [3]
References
1 Novel pathways of ponatinib disposition catalyzed by CYP1A1 involving generation of potentially toxic metabolites. J Pharmacol Exp Ther. 2017 Oct;363(1):12-19.
2 Absorption, metabolism, and excretion of [(14)C]ponatinib after a single oral dose in humans Cancer Chemother Pharmacol. 2017 Mar;79(3):507-518. doi: 10.1007/s00280-017-3240-x.
3 In vitro metabolites characterization of ponatinib in human liver microsomes using ultra-high performance liquid chromatography combined with Q-Exactive-Orbitrap tandem mass spectrometry Biomed Chromatogr. 2020 Jun;34(6):e4819. doi: 10.1002/bmc.4819.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.